[
  {
    "ts": null,
    "headline": "Reflecting On Therapeutics Stocks’ Q1 Earnings: Moderna (NASDAQ:MRNA)",
    "summary": "As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including Moderna (NASDAQ:MRNA) and its peers.",
    "url": "https://finnhub.io/api/news?id=8b301713c204a569f7d3882e144d59111a98379b487a404f35348ab2c760064e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752636663,
      "headline": "Reflecting On Therapeutics Stocks’ Q1 Earnings: Moderna (NASDAQ:MRNA)",
      "id": 135966555,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including Moderna (NASDAQ:MRNA) and its peers.",
      "url": "https://finnhub.io/api/news?id=8b301713c204a569f7d3882e144d59111a98379b487a404f35348ab2c760064e"
    }
  }
]